Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.

Alexander RankinDeepika DarbariAndrew CampbellJennifer WebbYunchuan Delores MoCyril JacquotMeghan DelaneyNaomi L C LubanRobert Sheppard Nickel

Published in: Transfusion (2021)

It is feasible to test for new RBC alloantibody development in most episodically transfused patients with SCD as part of their routine care. The yield of this screening appears low with CEK matching, but it could still provide important information for individual patients.

Keyphrases

red blood cell
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
palliative care
peritoneal dialysis
patient reported outcomes
cardiac surgery
sickle cell disease